A randomized comparison of azithromycin and doxycycline for the treatment of mycoplasma genitalium-positive urethritis in men

Clinical Infectious Diseases

Volumn 48, Issue 12, 2009, Pages 1649-1654

  Mena, Leandro A ^a   Mroczkowski, Tomasz F ^b   Nsuami, Malanda ^b   Martin, David H ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA GENITALIUM; NONSPECIFIC URETHRITIS; PRIORITY JOURNAL; RANDOMIZATION; RELAPSE; SINGLE DRUG DOSE; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DOXYCYCLINE; HUMANS; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; RECURRENCE; URETHRITIS; YOUNG ADULT;

EID: 66949160421     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599033     Document Type: Article

References (17)

1. Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981; 1:1288-91.
2. Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 2004; 18:1-11.
3. Maeda S, Deguchi T, Ishiko H, et al. Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Urea- plasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization. IntJUrol 2004;11:750-4.
4. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003;79:318-9.
5. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 2006;55(RR-11):1-94.
6. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000; 45(Suppl 1):29-33.
7. Hannan PC, Woodnutt G. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. J Antimicrob Chemother 2000; 45:367-9.
8. Hamasuna R, Osada Y, Jensen JS. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. Antimicrob Agents Chemother 2005; 49:4993-8.
9. Johannisson G, Enstrom Y, Lowhagen GB, et al. Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. Int J STD AIDS 2000; 11:324-6.
10. Bjornelius E, Anagrius C, Bojs G, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84:72-6.
11. Mena L, Wang X, Mroczkowski TF, Martin DH. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis 2002;35:1167- 73.
12. Horner PJ, Gilroy CB, Thomas BJ, Naidoo RO, Taylor-Robinson D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet 1993;342:582-5.
13. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12:1149-52.
14. Wagner T, Burns JL. Anti-inflammatory properties of macrolides. Pediatr Infect Dis J 2007;26:75-6.
15. Weinberg JM. The anti-inflammatory effects of tetracyclines. Cutis 2005; 75(Suppl 4):6-11.
16. Wikstrom A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006; 82:276-9.
17. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008; 3:e3618.